Outset Medical, Inc.
OM
$0.5781
$0.02514.54%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 2.79% | 4.67% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.79% | 4.67% | |||
| Cost of Revenue | -3.74% | 7.04% | |||
| Gross Profit | 15.34% | 0.39% | |||
| SG&A Expenses | -14.38% | -17.18% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.82% | -9.71% | |||
| Operating Income | 31.60% | 22.51% | |||
| Income Before Tax | 7.62% | 19.08% | |||
| Income Tax Expenses | -102.20% | 20.53% | |||
| Earnings from Continuing Operations | 8.24% | 18.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 8.24% | 18.91% | |||
| EBIT | 31.60% | 22.51% | |||
| EBITDA | 33.63% | 23.37% | |||
| EPS Basic | 12.15% | 16.68% | |||
| Normalized Basic EPS | 30.71% | 16.87% | |||
| EPS Diluted | 12.15% | 16.68% | |||
| Normalized Diluted EPS | 30.71% | 16.87% | |||
| Average Basic Shares Outstanding | 4.44% | -2.66% | |||
| Average Diluted Shares Outstanding | 4.44% | -2.66% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
